Amyloid Beta-directed Antibody drugs

2 medications in the FDA established pharmacologic class “Amyloid Beta-directed Antibody”.

DrugTypeNDC products
Lecanemab Autoinjector
Lecanemab-irmb
Rx2
Leqembi
Lecanemab
Rx2